BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11478264)

  • 1. Expression of sodium iodide symporter in benign and malignant human thyroid tissues.
    Lin JD; Hsueh C; Chao TC; Weng HF
    Endocr Pathol; 2001; 12(1):15-21. PubMed ID: 11478264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benign nonfunctioning thyroid adenomas are characterized by a defective targeting to cell membrane or a reduced expression of the sodium iodide symporter protein.
    Tonacchera M; Viacava P; Agretti P; de Marco G; Perri A; di Cosmo C; de Servi M; Miccoli P; Lippi F; Naccarato AG; Pinchera A; Chiovato L; Vitti P
    J Clin Endocrinol Metab; 2002 Jan; 87(1):352-7. PubMed ID: 11788674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of mRNA of sodium iodide symporter in benign and malignant human thyroid tissues.
    Liou MJ; Lin JD; Chan EC; Liu FH; Chao TC; Weng HF
    Cancer Lett; 2000 Nov; 160(1):75-80. PubMed ID: 11098087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Na+/I- symporter distribution in human thyroid tissues: an immunohistochemical study.
    Caillou B; Troalen F; Baudin E; Talbot M; Filetti S; Schlumberger M; Bidart JM
    J Clin Endocrinol Metab; 1998 Nov; 83(11):4102-6. PubMed ID: 9814499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of sodium iodide symporter in metastatic and follicular human thyroid tissues.
    Lin JD; Chan EC; Chao TC; Chen KT; Hsueh C; Ho YS; Weng HF
    Ann Oncol; 2000 May; 11(5):625-9. PubMed ID: 10907960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas.
    Park HJ; Kim JY; Park KY; Gong G; Hong SJ; Ahn IM
    Thyroid; 2000 Mar; 10(3):211-7. PubMed ID: 10779135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for transcriptional and posttranscriptional alterations of the sodium/iodide symporter expression in hypofunctioning benign and malignant thyroid tumors.
    Trouttet-Masson S; Selmi-Ruby S; Bernier-Valentin F; Porra V; Berger-Dutrieux N; Decaussin M; Peix JL; Perrin A; Bournaud C; Orgiazzi J; Borson-Chazot F; Franc B; Rousset B
    Am J Pathol; 2004 Jul; 165(1):25-34. PubMed ID: 15215159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of reverse transcription-competitive polymerase chain reaction method to quantitate the expression levels of human sodium iodide symporter.
    Ryu KY; Senokozlieff ME; Smanik PA; Wong MG; Siperstein AE; Duh QY; Clark OH; Mazzaferri EL; Jhiang SM
    Thyroid; 1999 Apr; 9(4):405-9. PubMed ID: 10319949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of low sodium-iodide symporter messenger ribonucleic acid expression in malignant thyroid nodules with increased intracellular protein staining.
    Sodré AK; Rubio IG; Galrão AL; Knobel M; Tomimori EK; Alves VA; Kanamura CT; Buchpiguel CA; Watanabe T; Friguglietti CU; Kulcsar MA; Medeiros-Neto G; Camargo RY
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4141-5. PubMed ID: 18628528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of human sodium/iodide symporter, thyroid transcription factor-1, and paired-box-protein-8 gene expression in benign thyroid diseases.
    Joba W; Spitzweg C; Schriever K; Heufelder AE
    Thyroid; 1999 May; 9(5):455-66. PubMed ID: 10365677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical studies of Na+/I- symporter in human thyroid tissues--a correlation with clinical thyroid scintigraphy.
    Lee CH; Yang AH; Chang JY; Huang CL; Chi CW
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Mar; 64(3):141-6. PubMed ID: 11458618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trefoil factor 3 immunohistochemical characterization of follicular thyroid lesions from tissue microarray.
    Patel MR; Bryson PC; Shores CG; Hart CF; Thorne LB; Deal AM; Zanation AM
    Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):590-6. PubMed ID: 19528408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein synthesis inhibitors, in synergy with 5-azacytidine, restore sodium/iodide symporter gene expression in human thyroid adenoma cell line, KAK-1, suggesting trans-active transcriptional repressor.
    Li W; Venkataraman GM; Ain KB
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1080-7. PubMed ID: 17164311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of iodide uptake in dedifferentiated thyroid carcinoma: relationship to human Na+/I-symporter gene methylation status.
    Venkataraman GM; Yatin M; Marcinek R; Ain KB
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2449-57. PubMed ID: 10404820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma: a note of caution.
    Sahoo S; Hoda SA; Rosai J; DeLellis RA
    Am J Clin Pathol; 2001 Nov; 116(5):696-702. PubMed ID: 11710686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human sodium iodide symporter (hNIS) in fibroadenoma breast--a immunohistochemical study.
    Rai R; Shrivastava A; Tandon A; Godbole MM; Kumar S; Das V; Dwivedi V; Pal L
    Indian J Exp Biol; 2011 Feb; 49(2):113-7. PubMed ID: 21428212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iodide kinetics and experimental (131)I therapy in a xenotransplanted human sodium-iodide symporter-transfected human follicular thyroid carcinoma cell line.
    Smit JW; Schröder-van der Elst JP; Karperien M; Que I; Stokkel M; van der Heide D; Romijn JA
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1247-53. PubMed ID: 11889195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies against the human sodium iodide symporter: utility for immunocytochemistry of thyroid cancer.
    Castro MR; Bergert ER; Beito TG; Roche PC; Ziesmer SC; Jhiang SM; Goellner JR; Morris JC
    J Endocrinol; 1999 Dec; 163(3):495-504. PubMed ID: 10588823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of correlation for sodium iodide symporter mRNA and protein expression and analysis of sodium iodide symporter promoter methylation in benign cold thyroid nodules.
    Neumann S; Schuchardt K; Reske A; Reske A; Emmrich P; Paschke R
    Thyroid; 2004 Feb; 14(2):99-111. PubMed ID: 15068624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
    Filetti S; Bidart JM; Arturi F; Caillou B; Russo D; Schlumberger M
    Eur J Endocrinol; 1999 Nov; 141(5):443-57. PubMed ID: 10576759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.